Recent News

• 09.08.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.08.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.03.2025 - Cantor Global Healthcare Conference 2025
• 09.03.2025 - Cantor Global Healthcare Conference 2025
• 08.27.2025 - Verastem Oncology to Present at Upcoming Investor Conferences
• 08.27.2025 - Verastem Oncology to Present at Upcoming Investor Conferences
• 08.13.2025 - Verastem Oncology Announces Late-Breaking Abstract from Partner GenFleet Therapeutics’ Study in China of GFH375 (VS-7375) in Advanced Non-Small Cell Lung Cancer at IASLC 2025 World Conference on Lung Cancer
• 08.13.2025 - Verastem Oncology Announces Late-Breaking Abstract from Partner GenFleet Therapeutics’ Study in China of GFH375 (VS-7375) in Advanced Non-Small Cell Lung Cancer at IASLC 2025 World Conference on Lung Cancer
• 08.07.2025 - Verastem Oncology 2Q25 Earnings Call

Recent Filings

• 08.15.2025 - EFFECT Notice of Effectiveness
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.13.2025 - EX-99.1 EX-99.1
• 08.13.2025 - 8-K Current report
• 08.13.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.13.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.12.2025 - S-3/A Registration statement under Securities Act of 1933
• 08.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors